palexia 50 mg film-coated tablets
grunenthal pharma ltd - tapentadol - film-coated tablet - 50 milligram(s) - other opioids; tapentadol
palexia 100 mg film-coated tablets
grunenthal pharma ltd - tapentadol - film-coated tablet - 100 milligram(s) - other opioids; tapentadol
palexia 4 mg/ml oral solution
grunenthal pharma ltd - tapentadol hydrochloride - oral solution - 4 milligram(s)/millilitre - other opioids; tapentadol
palexia 20 mg/ml oral solution
grunenthal pharma ltd - tapentadol hydrochloride - oral solution - 20 milligram(s)/millilitre - other opioids; tapentadol
apeneta 100 mg prolonged-release tablets
krka, d.d., novo mesto - tapentadol maleate hemihydrate - prolonged-release tablet - 100 milligram(s) - tapentadol
apeneta 150 mg prolonged-release tablets
krka, d.d., novo mesto - tapentadol maleate hemihydrate - prolonged-release tablet - 150 milligram(s) - tapentadol
apeneta 200 mg prolonged-release tablets
krka, d.d., novo mesto - tapentadol maleate hemihydrate - prolonged-release tablet - 200 milligram(s) - tapentadol
apeneta 250 mg prolonged-release tablets
krka, d.d., novo mesto - tapentadol maleate hemihydrate - prolonged-release tablet - 250 milligram(s) - tapentadol
apeneta 50 mg prolonged-release tablets
krka, d.d., novo mesto - tapentadol maleate hemihydrate - prolonged-release tablet - 50 milligram(s) - tapentadol
arrow - venlafaxine xr
teva pharma (new zealand) limited - venlafaxine hydrochloride 84.86mg equivalent to venlafaxine 75 mg; ; ; - modified release tablet - 75 mg - active: venlafaxine hydrochloride 84.86mg equivalent to venlafaxine 75 mg excipient: cellulose acetate colloidal silicon dioxide cellulose acetate 398-10 nf macrogol 400 magnesium stearate mannitol microcrystalline cellulose opadry white y-30-18037 povidone - · arrow – venlafaxine xr is indicated for the treatment of major depression. arrow – venlafaxine xr is also indicated for the prevention of relapse and recurrence of major depression where appropriate.